Condition category
Urological and Genital Diseases
Date applied
09/01/2019
Date assigned
18/01/2019
Last edited
20/06/2019
Prospective/Retrospective
Retrospectively registered
Overall trial status
Ongoing
Recruitment status
No longer recruiting

Plain English Summary

Background and study aims
High human papillomavirus (HPV) vaccination rates are key to decreasing the burden of HPV-related diseases. Most messages that promote HPV vaccination to college-aged individuals focus on the long-term consequences of HPV infection. Messages that focus more on short-term consequences of HPV infection may be more effective in this age group. The aim of this study is to see if a message focusing more on the short-term consequences of HPV infection, like genital warts, might increase a person’s intent to receive the HPV vaccine.

Who can participate?
Anyone who is between 18 and 23 years of age, lives in the United States, and has not completed the HPV vaccine series

What does the study involve?
Participation involves completing a short survey (5-10 minutes), viewing of a message with some pictures, and then completing another survey (15-20 minutes). Participants are randomly allocated to view either a message containing an image of a bird on a feeder and a brief description of birdfeeding, or a message containing images of genital warts and a brief description of a Tinder date leading to HPV infection. Intent to receive the HPV vaccine is measured using a survey immediately after the message has been reviewed by the participant.

What are the possible benefits and risks of participating?
The study is not intended to directly benefit participants. The risks in the study are likely to be small. There is a possibility of viewing images of a graphic nature, which some people may find disturbing. There is always a small chance that confidentiality will be broken despite extensive procedures to preserve confidentiality.

Where is the study run from?
The study is being run from Emory University (USA), but all study procedures (questionnaires and messages) take place online.

When is the study starting and how long is it expected to run for?
June 2017 to September 2019 (updated 20/06/2019, previously: June 2019)

Who is funding the study?
Emory University (USA)

Who is the main contact?
Avnika Amin

Trial website

Contact information

Type

Public

Primary contact

Ms Avnika Amin

ORCID ID

Contact details

1518 Clifton Rd
Atlanta
30322
United States of America

Type

Scientific

Additional contact

Dr Saad Omer

ORCID ID

Contact details

1518 Clifton Rd
Atlanta
30322
United States of America
+1 (0)4047279814
somer@emory.edu

Additional identifiers

EudraCT number

ClinicalTrials.gov number

Protocol/serial number

IRB00104624

Study information

Scientific title

HPV, genital warts, and purity: college-aged individuals’ perceptions of HPV and intention to receive the HPV vaccine

Acronym

Study hypothesis

Participants who read the interventional message will have a higher intent to receive HPV vaccine than participants who read the control message.

Ethics approval

Emory University Institutional Review Board, 1599 Clifton Road NE, 5th Floor, Atlanta, GA 30322, USA, Tel: +1 (0)404 712 0720, Email: IRB@emory.edu, 11/12/2018, ref: IRB00104624

Study design

This interventional study will randomize participants to receive either a visual message related to birdfeeding (control) or a visual message describing the consequences of HPV infection.

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Trial setting

Internet

Trial type

Prevention

Patient information sheet

Not available in web format, please use contact details to request a participant information sheet.

Condition

Intent to receive HPV vaccine

Intervention

Participants will be randomized using a Qualtrics algorithm. The algorithm randomly presents either the control or experimental visual message while ensuring that control and experimental group numbers are approximately balanced.

This interventional study will randomize participants to receive either:
Control: a visual message containing an image of a bird on a feeder and a brief description of birdfeeding.
Intervention: a visual message containing images of genital warts and a brief description of a Tinder date leading to HPV infection.

Intervention type

Behavioural

Phase

Drug names

Primary outcome measure

Intent to receive the HPV vaccine, measured once during a post-intervention survey administered immediately after the visual message has been reviewed by the participant. The method of measurement for the primary outcome is a single question asking if the participants intends to initiate (if they have received 0 HPV vaccine doses) or continue (if they have received 1-2 HPV vaccine doses) the HPV vaccine series.

Secondary outcome measures

Clicks on a link helping to locate the nearest vaccine clinic, measured using embedded data in the online survey administered immediately after the visual message has been reviewed by the participant.

Overall trial start date

01/06/2017

Overall trial end date

15/09/2019

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

1. Between 18 and 23 years of age (inclusive)
2. Resident of the United States
3. Has received no more than 2 doses of the HPV vaccine

Participant type

Healthy volunteer

Age group

Adult

Gender

Both

Target number of participants

5,049

Participant exclusion criteria

1. Has completed the HPV vaccine series (3 or more doses)
2. Has already completed the survey

Recruitment start date

15/01/2019

Recruitment end date

15/08/2019

Locations

Countries of recruitment

United States of America

Trial participating centre

Emory University Rollins School of Public Health
1518 Clifton Rd
Atlanta
30322
United States of America

Sponsor information

Organisation

Emory University Rollins School of Public Health

Sponsor details

1518 Clifton Rd
Atlanta
30322
United States of America

Sponsor type

University/education

Website

https://www.sph.emory.edu/

Funders

Funder type

Other

Funder name

Investigator initiated and funded

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

The study protocol, which contains a brief analysis plan, will be made available. Planned publication of the study results in a high-impact, peer-reviewed journal.

IPD sharing statement
Data will be available upon request from Avnika Amin to legitimate researchers with a brief, methodologically sound proposal. This includes de-identified individual participant data used to generate the results reported. The data will be available within one month of publication of the manuscript. After approval, data will be shared via a link (to be provided) and should only be used for the aims detailed in the approved proposals.

Intention to publish date

15/09/2020

Participant level data

Available on request

Basic results (scientific)

Publication list

Publication citations

Additional files

Editorial Notes

20/06/2019: The following changes were made to the trial record: 1. The recruitment end date was changed from 30/05/2019 to 15/08/2019. 2. The overall end date was changed from 30/06/2019 to 15/09/2019. 3. The intention to publish date was changed from 30/06/2020 to 15/09/2020. 4. The plain English summary was updated to reflect these changes.